Study Shows Polygenic Risk Score (PGS) Could Predict Breast Cancer Survival Outcomes
Roswell Park Comprehensive Cancer CenterData from a large prospective cohort study reveal that a polygenic risk score has the potential to predict survival outcomes in patients with breast cancer. Arya Mariam Roy, MBBS, Hematology/Oncology Fellow (Class of 2024) at Roswell Park Comprehensive Cancer Center, will share the results of that study as the first and presenting author of “Breast cancer polygenic risk score and patient survival outcomes in the Pathways study” at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31-June 4.